Total Payments
$2,997
2024 Payments
$65.14
Companies
32
Transactions
230
Medicare Patients
1,245
Medicare Billing
$142,896
Payment Breakdown by Category
Food & Beverage$2,988 (99.7%)
Education$8.82 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,988 | 227 | 99.7% |
| Education | $8.82 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $577.47 | 66 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $414.66 | 26 | $0 (2024) |
| Novo Nordisk Inc | $273.17 | 24 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $264.47 | 21 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $237.19 | 11 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $173.61 | 11 | $0 (2024) |
| Amgen Inc. | $159.53 | 9 | $0 (2019) |
| GlaxoSmithKline, LLC. | $146.64 | 11 | $0 (2019) |
| Astellas Pharma US Inc | $123.87 | 6 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $102.82 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65.14 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($25.74) |
| 2023 | $113.23 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($52.08) |
| 2022 | $96.72 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($52.87) |
| 2021 | $243.26 | 14 | E.R. Squibb & Sons, L.L.C. ($59.22) |
| 2020 | $75.54 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($23.41) |
| 2019 | $723.03 | 57 | PFIZER INC. ($183.38) |
| 2018 | $786.14 | 61 | PFIZER INC. ($217.60) |
| 2017 | $893.64 | 81 | PFIZER INC. ($159.70) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 2 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/11/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.12 | General |
| Category: Cardiovascular | ||||||
| 01/13/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.18 | General |
| Category: Cardiovascular | ||||||
| 09/15/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $18.71 | General |
| 07/17/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/16/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Respiratory and Allergy | ||||||
| 06/16/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), STIOLTO RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: DIABETES | ||||||
| 09/19/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/18/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/16/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: Obesity | ||||||
| 09/10/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Endocrinology | ||||||
| 09/09/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Neuroscience | ||||||
| 09/05/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Diabetes | ||||||
| 09/04/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Neuroscience | ||||||
| 08/13/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/13/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/07/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/05/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/17/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Bone Health | ||||||
| 07/15/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/15/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $0.83 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/08/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: Diabetes | ||||||
| 07/08/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: Diabetes | ||||||
| 06/27/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: DIABETES | ||||||
| 06/26/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 175 | 285 | $47,946 | $20,572 |
| 2022 | 4 | 256 | 454 | $75,818 | $31,373 |
| 2021 | 4 | 448 | 859 | $122,013 | $60,451 |
| 2020 | 5 | 366 | 512 | $77,577 | $30,500 |
Total Patients
1,245
Total Services
2,110
Medicare Billing
$142,896
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 100 | 199 | $25,074 | $11,972 | 47.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 32 | $11,200 | $3,874 | 34.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 28 | $5,068 | $2,529 | 49.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 25 | 26 | $6,604 | $2,197 | 33.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 148 | 338 | $42,588 | $17,978 | 42.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 57 | 59 | $20,650 | $9,089 | 44.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 30 | 31 | $7,874 | $2,483 | 31.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 26 | $4,706 | $1,822 | 38.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 282 | 678 | $76,628 | $38,429 | 50.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 80 | 81 | $26,661 | $13,952 | 52.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 62 | 62 | $12,409 | $5,041 | 40.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 38 | $6,315 | $3,029 | 48.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 98 | 197 | $20,488 | $11,267 | 55.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 56 | 57 | $16,530 | $8,787 | 53.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 152 | 192 | $31,104 | $7,313 | 23.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 27 | 28 | $5,348 | $2,371 | 44.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 38 | $4,107 | $762.41 | 18.6% |
About Dr. David Folkmier, D.O
Dr. David Folkmier, D.O is a Internal Medicine healthcare provider based in Muskegon, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1871587287.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Folkmier, D.O has received a total of $2,997 in payments from pharmaceutical and medical device companies, with $65.14 received in 2024. These payments were reported across 230 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,988).
As a Medicare-enrolled provider, Folkmier has provided services to 1,245 Medicare beneficiaries, totaling 2,110 services with total Medicare billing of $142,896. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Muskegon, MI
- Active Since 08/31/2005
- Last Updated 04/23/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871587287
Products in Payments
- JARDIANCE (Drug) $332.04
- CHANTIX (Drug) $277.43
- ENTRESTO (Drug) $237.19
- XARELTO (Drug) $226.95
- ELIQUIS (Drug) $181.59
- LYRICA (Drug) $142.59
- Tresiba (Drug) $112.15
- TOUJEO (Drug) $87.50
- MYRBETRIQ (Drug) $85.12
- VIAGRA (Drug) $85.01
- Aimovig (Biological) $79.38
- FARXIGA (Drug) $53.74
- PRADAXA (Drug) $50.52
- BREO (Drug) $45.85
- ANORO (Drug) $44.81
- CAMZYOS (Drug) $43.67
- Ozempic (Drug) $38.31
- Prolia (Biological) $36.27
- INVOKANA (Drug) $35.12
- YUPELRI (Drug) $34.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Muskegon
Dr. Sarah Gunther, Do, DO
Internal Medicine — Payments: $12,449
Internal Medicine $12,449
Varun Yelamanchili, Md, MD
Internal Medicine — Payments: $10,786
Internal Medicine $10,786
Soaries Peterson, Ph.d., M.d, PH.D., M.D
Internal Medicine — Payments: $8,151
Internal Medicine $8,151
Dr. Scott Harris, D.o, D.O
Internal Medicine — Payments: $6,244
Internal Medicine $6,244
Dr. Hikmat Halasa, Md, MD
Internal Medicine — Payments: $4,737
Internal Medicine $4,737
Mathew Brakora, Md, MD
Internal Medicine — Payments: $3,940
Internal Medicine $3,940